!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Weather Update

Baylor College of Medicine will be open today and Baylor Medicine will be seeing patients. Please prioritize your safety and take appropriate safety precautions if driving in any high water. View message. 

Department of Medicine

Chief's Message

Master
Media Component
Martha Mims
Content

The Section of Hematology and Oncology is at the forefront of education, research and treatment for hematologic and oncologic disorders. Faculty members have strong affiliations with the Dan L Duncan Comprehensive Cancer Center, the Lester and Sue Smith Breast Center and the Center for Cell and Gene Therapy. Our outstanding clinicians serve patients at Baylor St Luke's Medical Center and the McNair Clinic, Ben Taub Hospital and Smith Clinic, the Michael E. DeBakey VA Medical Center, the Cellular Therapy Unit at Houston Methodist Hospital and the Pavilion for Women.

Basic and translational scientists in the section are leaders in cell signaling, breast and prostate cancer research, benign hematologic disorders, and cellular therapy. There are strong clinical research programs at all sites with special expertise in GI malignancies, Breast cancer, GU cancers, hematologic malignancies and cellular therapy.

The section is dedicated to training medical students, residents and fellows in the classroom and at the bedside, and to educating graduate students and postdoctoral fellows in our laboratories.  Our fellowship program is one of the largest in the country with comprehensive clinical training and research opportunities.

Please explore our website and learn more about our many programs all focused on understanding and treating hematologic and oncologic disorders.  

Martha Pritchett Mims, M.D., Ph.D.
Chief, Section of Hemetology and Oncology